Bukhman Foundation announces £100 milion commitment towards Type 1 Diabetes
16 May 2025A 10 year commitment to accelerate groundbreaking research and bring new treatments and a...
Type 1 Diabetes
T1D medical research drives progress, offering hope and transforming lives through innovation and discovery.
At the Bukhman Foundation, one of our core missions is to find a cure for people affected by Type 1 Diabetes (T1D). We are committed to advancing research that moves us closer, while understanding that a “cure” can mean many things. For us, it’s not only about a scientific breakthrough, it’s about reaching a point where people no longer have to think about their condition every day, where the burden of injections, calculations, and constant vigilance fades into the background of daily life.
We believe that bold ideas and visionary leadership can get us there. By partnering with researchers who push boundaries and challenge conventional thinking, we aim to build a future where T1D no longer limits how people live, dream, and thrive.
Our approach to funding medical research is grounded in partnership, trust, and long-term ambition. We support cutting-edge science, promote open research, and encourage collaboration between leading experts and institutions across the globe.
We look for projects that accelerate the development of new treatments, prioritise transparency, and share discoveries widely, amplifying impact across the field. By backing research that is ambitious, rigorous, and transformative, we aim to unlock real progress and move closer to a world where living with T1D is no longer a daily struggle.